The 340B Drug Pricing Program: Helping Hospitals Keep Patients & Communities Healthy

PDF of infographic urges Congress preserve the 340B program to protect access to care.

Key Resources

Related Resources

Special Bulletin
HRSA Finalizes Rule on 340B Dispute Resolution Process
Public
At A Glance The Health Resources and Services Administration (HRSA) Dec. 10 released its long-awaited final rule implementing an Affordable Care Act (ACA)…
Special Bulletin
CMS Issues Hospital Outpatient/ASC Final Rule, Including Maintenance of 340B Cuts
Public
At A Glance The Centers for Medicare & Medicaid Services (CMS) yesterday released the calendar year (CY) 2021 outpatient prospective payment system (…
Special Bulletin
Special Bulletin: CMS Issues Interim Final Rule Implementing Most Favored Nation Model for Part B Drugs
Public
The Centers for Medicare & Medicaid Services (CMS) Nov. 20 released an interim final rule implementing the Most Favored Nation (MFN) Model, a new payment…
Letter/Comment
AHA letter to HRSA on 340B Program and Kalderos Issue
Public
The AHA on Friday sent a letter to the Health Resources and Services Administration’s Office of Pharmacy Affairs urging the agency to order drug manufacturers…
Letter/Comment
AHA Expresses Strong Support of the 340B Drug Pricing Program
Public
In a letter to Senator Lamar Alexander and Representative Greg Walden, AHA expresses strong support for the 340B Drug Pricing Program.
Action Alert
Deadline Extended Until Oct. 29 for Your Representatives to Sign ‘Dear Colleague’ Letter
Member
Please contact your representatives today and ask them to sign onto a bipartisan “Dear Colleague” letter to Department of Health and Human Services Secretary…